249 related articles for article (PubMed ID: 6417628)
1. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
Furst DE
Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
[TBL] [Abstract][Full Text] [Related]
2. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
[No Abstract] [Full Text] [Related]
3. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
4. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
Horton RJ
Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
[TBL] [Abstract][Full Text] [Related]
5. Auranofin: experience to date.
Blodgett RC
Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the kinetics of parenteral and oral gold.
Gottlieb NL
Scand J Rheumatol Suppl; 1983; 51():10-4. PubMed ID: 6426043
[TBL] [Abstract][Full Text] [Related]
7. Oral chrysotherapy in rheumatoid arthritis: auranofin. Cleveland Clinic experience and literature review.
Mazanec DJ; Segal AM; Mackenzie AH; Lippert M
Cleve Clin Q; 1985; 52(2):123-8. PubMed ID: 3928200
[No Abstract] [Full Text] [Related]
8. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO
Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595
[TBL] [Abstract][Full Text] [Related]
9. Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritis.
Davies J; Bacon PA; Hall ND; Ring EF
Clin Rheumatol; 1984 Dec; 3(4):553-4. PubMed ID: 6441670
[No Abstract] [Full Text] [Related]
10. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
Batlle Gualda E
Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
[No Abstract] [Full Text] [Related]
11. Auranofin therapy in rheumatoid arthritis.
Bernhard GC
J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
[TBL] [Abstract][Full Text] [Related]
12. Biologic actions and pharmacokinetic studies of auranofin.
Walz DT; DiMartino MJ; Griswold DE; Intoccia AP; Flanagan TL
Am J Med; 1983 Dec; 75(6A):90-108. PubMed ID: 6318557
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological profile of auranofin, an orally active gold compound.
Walz DT; DiMartino MJ; Griswold DE
Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
Wessel J; Davis P
J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
[No Abstract] [Full Text] [Related]
15. Gold concentrations and toxicity during oral gold treatment with auranofin.
Sharma RP; Smillie J; Palmer DG
Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
[TBL] [Abstract][Full Text] [Related]
16. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
17. [Multicenter double-blind comparison of auranofin and Tauredon].
Kaik B; Bröll H
Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
[TBL] [Abstract][Full Text] [Related]
18. Auranofin.
Davis P
Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
[TBL] [Abstract][Full Text] [Related]
19. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of oral and injectable gold compounds.
Blocka KL; Paulus HE; Furst DE
Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
